Internal Medicine, Hematology · New Brunswick, NJ
NPI
1548689763
Since 2014
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
125 Paterson St Ste 5200
New Brunswick, NJ, 08901
Phone (732) 235-7223
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
893 services
Medicare patients, 2024
208
Average age 71
Drug cost, 2024
$3.1M
693 prescriptions
Company payments, 2025
$110K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mansi R Shah was code 99215 (office e&m - established), 302 times for 134 patients. In total Mansi R Shah billed 893 services in 14 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 302 | 134 | $148.45 | $45K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 143 | 56 | $27.02 | $3,864 |
| 99233 Hospital E&M - Subsequent | Facility | 135 | 40 | $100.12 | $14K |
| 99215 Office E&M - Established | Facility | 83 | 66 | $77.20 | $6,408 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 63 | 29 | $22.95 | $1,446 |
| 99223 Hospital E&M - Initial | Facility | 44 | 41 | $143.60 | $6,318 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 43 | 34 | $13.41 | $577 |
| 99205 Office E&M - New | Office | 22 | 22 | $187.45 | $4,124 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 22 | 15 | $25.66 | $565 |
By year: 2022 $64K for 716 services; 2023 $70K for 860 services; 2024 $85K for 893 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mansi R Shah prescribed most often to Medicare patients was Acyclovir, with 96 prescriptions and refills. In total Mansi R Shah wrote 693 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 96 | 186 | 48 | $1,190 |
| Pomalyst Pomalidomide | 47 | 47 | 25 | $1.1M |
| Revlimid Lenalidomide | 42 | 42 | 23 | $760K |
| Eliquis Apixaban | 37 | 49 | 11 | $29K |
| Lenalidomide Generic | 28 | 28 | 17 | $388K |
| Onureg Azacitidine | 26 | 26 | Under 11 | $586K |
| Gabapentin Generic | 24 | 59 | 14 | $436 |
| Duloxetine Hcl Generic | 22 | 42 | Under 11 | $315 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 22 | 24 | Under 11 | $769 |
| Levofloxacin Generic | 21 | 21 | 21 | $205 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 33 | 14 | $142 |
| Montelukast Sodium Generic | 20 | 32 | Under 11 | $188 |
| Dexamethasone Generic | 19 | 27 | 15 | $323 |
| Ondansetron Hcl Generic | 17 | 17 | 11 | $446 |
| Prochlorperazine Maleate Generic | 15 | 15 | Under 11 | $210 |
Brand drugs: 208 claims; generic drugs: 485 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mansi R Shah $110K ($101K in general payments such as food, travel and fees and $8,836 for research) from 13 companies. The largest payer was Janssen Biotech, Inc. with $69K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 77 | $69K |
| Regeneron Pharmaceuticals, Inc. REGN | 33 | $15K |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $10K |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $5,750 |
| Pfizer Inc. PFE | 4 | $5,561 |
| Janssen Global Services, LLC JNJ | 1 | $2,420 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $1,375 |
| Celgene Corporation BMY | 3 | $734 |
| Incyte Corporation INCY | 1 | $130 |
| Genzyme Corporation SNY | 1 | $71.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.